Tech China weekly highlights shanghaisun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shanghaisun.com Daily Mail and Mail on Sunday newspapers.
2021-02-06 14:06:07 GMT2021-02-06 22:06:07(Beijing Time) Xinhua English
A staff member of Sinovac Biotech, a Chinese biopharmaceutical company, displays a dose of COVID-19 inactivated vaccine in Schering bottle package in Beijing, capital of China, Dec. 23, 2020. China's National Medical Products Administration on Friday granted conditional market approval to CoronaVac, an inactivated COVID-19 vaccine developed by Sinovac Biotech, the company said on Saturday. (Xinhua/Zhang Yuwei)
BEIJING, Feb. 6 (Xinhua) China s National Medical Products Administration (NMPA) on Friday granted conditional market approval to CoronaVac, an inactivated COVID-19 vaccine developed by Sinovac Biotech, the company said on Saturday.
The Sinovac vaccine, produced by the Beijing-based Sinovac Life Sciences Co. Ltd., affiliated with Sinovac Biotech, was approved for emergency use in China last June. The vaccine started being used for emergency inoculation among some special groups in
About 500 million doses of the CoronaVac vaccine developed by Beijing-based Sinovac Life Sciences can be produced each year in the capital s southern suburbs.